PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $275,783 | -53.8% | 6,781 | -44.9% | 0.01% | -57.1% |
Q1 2023 | $596,635 | +129.7% | 12,317 | +81.0% | 0.01% | +100.0% |
Q4 2022 | $259,747 | -26.6% | 6,805 | -3.5% | 0.01% | -36.4% |
Q3 2022 | $354,000 | +34.1% | 7,055 | +6.9% | 0.01% | +37.5% |
Q2 2022 | $264,000 | +30.7% | 6,599 | +37.9% | 0.01% | -11.1% |
Q2 2021 | $202,000 | -11.0% | 4,785 | 0.0% | 0.01% | -10.0% |
Q1 2021 | $227,000 | -22.3% | 4,785 | -0.0% | 0.01% | 0.0% |
Q4 2020 | $292,000 | +22.2% | 4,786 | -6.5% | 0.01% | +25.0% |
Q3 2020 | $239,000 | -8.1% | 5,119 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $260,000 | +12.6% | 5,119 | -1.0% | 0.01% | +33.3% |
Q1 2020 | $231,000 | -6.5% | 5,170 | +0.7% | 0.01% | +20.0% |
Q4 2019 | $247,000 | +6.9% | 5,133 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $231,000 | -39.2% | 5,133 | -53.7% | 0.00% | -33.3% |
Q4 2018 | $380,000 | -37.0% | 11,079 | -13.7% | 0.01% | -25.0% |
Q3 2018 | $603,000 | +47.1% | 12,840 | +5.7% | 0.01% | +33.3% |
Q2 2018 | $410,000 | +3.5% | 12,151 | -38.6% | 0.01% | 0.0% |
Q3 2017 | $396,000 | – | 19,796 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,155,000 | $101,285,000 | 11.24% |
RTW INVESTMENTS, LP | 3,275,591 | $153,953,000 | 9.22% |
Asymmetry Capital Management, L.P. | 173,010 | $8,131,000 | 7.51% |
GREAT POINT PARTNERS LLC | 717,458 | $33,721,000 | 5.26% |
Ghost Tree Capital, LLC | 500,000 | $23,500,000 | 5.00% |
MAK CAPITAL ONE LLC | 221,723 | $10,421,000 | 3.41% |
Opaleye Management Inc. | 180,000 | $8,460,000 | 2.15% |
Avoro Capital Advisors LLC | 684,000 | $32,148,000 | 1.48% |
SCOPIA CAPITAL MANAGEMENT LP | 1,616,998 | $75,999,000 | 1.46% |
SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $9,870,000 | 1.13% |